ADVAGEN PHARMA EUROPE OÜ
Date of report 13.02.2025
Open the reports you want to print
Employees and salaries
ADVAGEN PHARMA EUROPE OÜ
Employee taxes and performance analysis?
| Quarter | Labor taxes paid | Number of employees | Turnover Per Employee | Profit per employee |
|---|---|---|---|---|
| 2024 IV | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... |
| 2023 IV | ...... | ...... | ...... | ...... |
| 2023 III | ...... | ...... | ...... | ...... |
| 2023 II | ...... | ...... | ...... | ...... |
Deciders and beneficiaries
ADVAGEN PHARMA EUROPE OÜ
Decision-makers?
Relations: 1
Turnover:
Employees:
Pratibha Pilgaonkar
★☆☆☆
......
Credit Score: Trustworthy
Reputation score: 660
Date of birth: ......
Active relations 1
*Every member of the management board may represent the private limited company in concluding all transactions.
ADVAGEN PHARMA EUROPE OÜ
History of right of representation?
Field
Manufactoring
Business age
1y
Beneficial country:
United States of America
Pratibha Pilgaonkar ... - ...
2023
2024
2025
2023
2024
2025
ADVAGEN PHARMA EUROPE OÜ
Owners?
Former owners
ADVAGEN PHARMA EUROPE OÜ
Other related parties?
Former other persons
Finances and assets
ADVAGEN PHARMA EUROPE OÜ
GoodwillADVAGEN PHARMA EUROPE OÜ
Taxes paid and estimated average salariesADVAGEN PHARMA EUROPE OÜ
Quarterly indicators| Quarter | Turnover | Taxed turnover | Labour productivity | Labour productivity | Employees | National taxes | Labor taxes |
|---|---|---|---|---|---|---|---|
| 2024 IV | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2024 III | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2024 II | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2024 I | ...... | ...... | ...... | ...... | ...... | ...... | ...... |
| 2023 IV | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 III | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
| 2023 II | * ...... | ...... | * ...... | ...... | ...... | ...... | ...... |
ADVAGEN PHARMA EUROPE OÜ
Sales revenue by business areaADVAGEN PHARMA EUROPE OÜ
Sales revenue by countryADVAGEN PHARMA EUROPE OÜ
Financial indicators and prognosisADVAGEN PHARMA EUROPE OÜ
Financial raiting: "GOOD" (2024 prognosis)2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good
ADVAGEN PHARMA EUROPE OÜ
Annual reports| Year | Period | Submitted | Report PDF |
|---|---|---|---|
| 2023 | 01.04.2023–31.03.2024 | 28.01.2025 | ...... |
Liabilities and debts
ADVAGEN PHARMA EUROPE OÜ
Credit score history and prognosisRecommended credit limit
... €
Recommended payment term
......
Business risk classes:
Trustworthy Neutral Borderline Problematic Risky
ADVAGEN PHARMA EUROPE OÜ
Reports and assets-liabilities overview 13.02.2025?
Annual reports: ......
Annual reports: ......
Tax declarations:......
Assets to cover liabilities (short-term)
Assets: ...... €1 EURO of assets to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €
ADVAGEN PHARMA EUROPE OÜ
Claims history?
Debt claims as of ......
Total debt claims: ...... €
Latest events
| ...... | ...... |
ADVAGEN PHARMA EUROPE OÜ
Income (turnover) and expenditure (taxes paid)?
| Quarter | Turnover | Taxed turnover | National taxes paid | Labor taxes paid | Number of employees |
|---|---|---|---|---|---|
| 2024 IV | ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 III | ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 II | ...... € | ...... € | ...... € | ...... € | ...... |
| 2024 I | ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 IV | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 III | * ...... € | ...... € | ...... € | ...... € | ...... |
| 2023 II | * ...... € | ...... € | ...... € | ...... € | ...... |
ADVAGEN PHARMA EUROPE OÜ
Bailiff's enforcement proceedings as of 13.02.2025?
Bailiff's enforcement proceedings MISSING
ADVAGEN PHARMA EUROPE OÜ
Regulations of the Payment Order Department as of 13.02.2025?
Regulations of the Payment Order Department MISSING
ADVAGEN PHARMA EUROPE OÜ
Court orders in the register as of 13.02.2025?
Hoiatusmäärus registrist kustutamiseks: majandusaasta aruanne esitamata
11.11.2024
Regulation number: Ä 50228219 / M4
Regulation status has entered into force: 11.11.2024
Date of enforcement of order or additional period: 11.11.2024
Regulation status: Jõustunud
Puuduste kõrvaldamise määrus
17.06.2024
Regulation number: Ä 50228219 / M3
Regulation status has entered into force: 19.06.2024
Date of enforcement of order or additional period: 20.06.2024
Regulation status: Puudused kõrvaldatud
Hoiatusmäärus registrist kustutamiseks: kontaktisiku mittevastavus
20.05.2024
Regulation number: Ä 50228219 / M2
Regulation status has entered into force: 20.05.2024
Date of enforcement of order or additional period: 20.05.2024
Regulation status: Jõustunud
Puuduste kõrvaldamise määrus
10.05.2023
Regulation number: Ä 50228219 / M1
Regulation status has entered into force: 14.05.2023
Date of enforcement of order or additional period: 15.05.2023
Regulation status: Puudused kõrvaldatud
ADVAGEN PHARMA EUROPE OÜ
Decisions of the Consumer Disputes Committee as of 13.02.2025?
Consumer disputes MISSING
ADVAGEN PHARMA EUROPE OÜ
Court hearings as of 13.02.2025?
Court hearings MISSING
ADVAGEN PHARMA EUROPE OÜ
Rulings as of 13.02.2025?
Court settlemets MISSING
ADVAGEN PHARMA EUROPE OÜ
Notices and announcements as of 13.02.2025?
Announcements MISSING
Marketing
Business network
ADVAGEN PHARMA EUROPE OÜ
Business networkCREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired
Beneficiaries network
ADVAGEN PHARMA EUROPE OÜ
Networks - Beneficiaries The network is visible with reduced links
Expand threads if desired
Monitoring events
Filter
Dropdown
Dropdown
Neutral
Positive
Negative
No monitoring events found.
Failed to load monitoring events.